Phenomix Sciences

Phenomix Sciences is a biotechnology company based in Minnetonka, Minnesota. The company employs 7 people and generates an annual revenue of $2.5 million. Phenomix Sciences specializes in precision medicine for obesity treatment. They focus on phenotyping, the study of how genes, environmental factors, and behavior interplay to influence obesity. Their goal is to utilize this knowledge to create personalized weight loss treatment plans that are more effective for each individual patient. The company was founded by Mayo Clinic medical professionals, Dr. Acosta and Dr. Camilleri, who believe that achieving better results in obesity treatment relies on access to comprehensive clinical and molecular information at all stages of the disease. Phenomix Sciences leverages data intelligence to improve the accuracy of predicting how individual patients will respond to various weight loss interventions. For more information about Phenomix Sciences and their precision medicine approach to obesity treatment, visit their website at phenomixsciences.com.